| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |